167 results match your criteria: "Johns Hopkins All Children's Heart Institute[Affiliation]"
Ann Surg
September 2015
*Department of Surgery and Center for Quality and Safety, Massachusetts General Hospital, Boston, MA †Division of Cardiothoracic Surgery, University of Colorado, Aurora, CO ‡Department of Cardiac Surgery, University of Michigan Health System, Ann Arbor, MI §Division of Cardiothoracic Surgery, University of Florida, Gainesville, FL ¶Institute for Health Care Research and Improvement, Baylor Health Care System, Dallas, TX ∥Duke Clinical Research Institute, Durham, NC **Starr-Wood Cardiac Group, Portland, OR ††Vanderbilt University, Nashville, TN ‡‡Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA §§HCA North Texas Division, Dallas, TX ¶¶Society of Thoracic Surgeons, Chicago, IL ∥∥Johns Hopkins All Children's Heart Institute, All Children's Hospital, St. Petersburg, FL.
Objectives: To evaluate participant characteristics and outcomes during the first 4 years of the Society of Thoracic Surgeons (STS) public reporting program.
Background: This is the first detailed analysis of a national, voluntary, cardiac surgery public reporting program using STS clinical registry data and National Quality Forum-endorsed performance measures.
Methods: The distributions of risk-adjusted mortality rates, multidimensional composite performance scores, star ratings, and volumes for public reporting versus nonreporting sites were studied during 9 consecutive semiannual reporting periods (2010-2014).
Ann Thorac Surg
September 2015
Johns Hopkins All Children's Heart Institute, Saint Petersburg, Tampa, and Orlando, Florida; Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Florida Hospital for Children, Orlando, Florida.
Background: The empirically derived 2014 Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model incorporates adjustment for procedure type and patient-specific factors. The purpose of this report is to describe this model and its application in the assessment of variation in outcomes across centers.
Methods: All index cardiac operations in The Society of Thoracic Surgeons Congenital Heart Surgery Database (January 1, 2010, to December 31, 2013) were eligible for inclusion.
Ann Thorac Surg
September 2015
Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Johns Hopkins All Children's Heart Institute, Saint Petersburg, Tampa, and Orlando, Florida; Florida Hospital for Children, Orlando, Florida.
Background: Accurate hospital outcome measures in congenital heart surgery are important to multiple initiatives. While methods have been developed to account for differences in procedural case-mix, characteristics patients bring into the operation that may also vary across hospitals and influence outcome have received less attention. We evaluated the impact of these characteristics in a large cohort.
View Article and Find Full Text PDFAnn Thorac Surg
September 2015
Johns Hopkins All Children's Heart Institute, Saint Petersburg, Tampa, and Orlando, Florida; Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Florida Hospital for Children, Orlando, Florida.
Background: This study's objective was to develop a risk model incorporating procedure type and patient factors to be used for case-mix adjustment in the analysis of hospital-specific operative mortality rates after congenital cardiac operations.
Methods: Included were patients of all ages undergoing cardiac operations, with or without cardiopulmonary bypass, at centers participating in The Society of Thoracic Surgeons Congenital Heart Surgery Database during January 1, 2010, to December 31, 2013. Excluded were isolated patent ductus arteriosus closures in patients weighing less than or equal to 2.
Ann Thorac Surg
October 2015
Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:
Background: Reoperative aortic valve replacement (re-AVR) after previous AVR is a complex procedure involving redo sternotomy and removal of a previous prosthesis. With increasing use of valve-in-valve transcatheter aortic valve replacement for failed aortic bioprostheses, an evaluation of contemporary outcomes of re-AVR in patients with bioprostheses is warranted.
Methods: The study included 3,380 patients from The Society of Thoracic Surgeons Adult Cardiac Surgery Database (July 2011 to September 2013) who underwent elective, isolated re-AVR after a previous AVR.
Ann Thorac Surg
July 2015
Division of Pediatric Cardiothoracic Surgery, Benioff Children's Hospital, University of California, San Francisco, San Francisco, California.
Background: As less invasive alternatives to surgical pulmonary valve replacement (PVR) are being refined and evaluated, there is a need for benchmark data concerning outcomes from surgical PVR.
Methods: We examined in-hospital outcomes from surgical PVR in The Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) and Adult Cardiac Surgery Database (STS-ACSD) between 2007 and 2013, with a focus on patients likely to be eligible for transcatheter PVR (ie, ≥ 5 years age and ≥ 30 kg). Patient characteristics, morbidity, and mortality were described.
Pediatrics
May 2015
Boston Children's Hospital, Boston, Massachusetts;
Background: Neurodevelopmental disability is the most common complication for survivors of surgery for congenital heart disease (CHD).
Methods: We analyzed individual participant data from studies of children evaluated with the Bayley Scales of Infant Development, second edition, after cardiac surgery between 1996 and 2009. The primary outcome was Psychomotor Development Index (PDI), and the secondary outcome was Mental Development Index (MDI).
J Thorac Cardiovasc Surg
June 2015
Division of Cardiothoracic Surgery, Johns Hopkins All Children's Heart Institute, St Petersburg, Fla.
Cardiol Young
December 2014
Johns Hopkins All Children's Heart Institute, All Children's Hospital,Saint Petersburg,Florida,United States of America.
Neonatal aortic valvar stenosis can be challenging to treat because of the varied morphology of the valve, the association with hypoplasia of other left heart structures, and the presence of left ventricular systolic dysfunction or endomyocardial fibroelastosis. Balloon valvuloplasty and surgical valvotomy have been well described in the literature for the treatment of neonatal aortic stenosis. Transcatheter therapy for neonatal aortic stenosis is the preferred method at many centres; however, some centres prefer a surgical approach.
View Article and Find Full Text PDFCardiol Young
December 2014
Johns Hopkins All Children's Heart Institute,Saint Petersburg,Florida,United States of America.
Pulmonary valve replacement in patients with congenital cardiac disease is now being performed with more liberal indications in light of the data that chronic pulmonary insufficiency is not a benign lesion. The beneficial effects of valve replacement with low operative mortality and morbidity support this approach. Many options exist for a pulmonary valve prosthesis, which underscores the fact that there is no ideal valve available.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
November 2014
Johns Hopkins All Children's Heart Institute, All Children's Hospital and Florida Hospital for Children, Johns Hopkins University, Saint Petersburg, Fla. Electronic address:
World J Pediatr Congenit Heart Surg
October 2014
Johns Hopkins University, Florida Hospital for Children, Orlando, FL, USA
Background: Anomalous aortic origin of a coronary artery (AAOCA) encompasses a wide morphologic spectrum, which has impeded consensus regarding indications for the diverse repair strategies. We constructed a profile of current surgical techniques and explore their application to morphologic variants.
Methods: Patients<30 years old (n=113) with isolated AAOCA who underwent operations at 29 Congenital Heart Surgeons Society (CHSS) institutions from 1998 to 2012 were identified from the CHSS AAOCA Registry.
Ann Thorac Surg
November 2014
Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Background: The most common forms of risk adjustment for pediatric and congenital heart surgery used today are based mainly on the estimated risk of mortality of the primary procedure of the operation. The goals of this analysis were to assess the association of patient-specific preoperative factors with mortality and to determine which of these preoperative factors to include in future pediatric and congenital cardiac surgical risk models.
Methods: All index cardiac operations in The Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) during 2010 through 2012 were eligible for inclusion.
J Heart Lung Transplant
June 2015
Congenital Heart Institute of Florida, St. Petersburg, Florida.
Background: Cardiac regenerative responses are responsive to paracrine factors. We hypothesize that chronic heart failure (HF) in pediatric patients affects cardiac paracrine signaling relevant to resident c-kit(+)cluster of differentiation (CD)34- cardiac stem cells (CSCs).
Methods: Discarded atrial septum (huAS) and atrial appendages (huAA) from pediatric patients with HF (huAA-HF; n = 10) or without HF (n = 3) were explanted and suspension explant cultured in media.
J Thorac Cardiovasc Surg
November 2014
Children's Hospital Boston and Harvard Medical School, Boston, Mass.
Objectives: The technical performance score (TPS) has been reported in a single center study to predict the outcomes after congenital cardiac surgery. We sought to determine the association of the TPS with outcomes in patients undergoing the Norwood procedure in the Single Ventricle Reconstruction trial.
Methods: We calculated the TPS (class 1, optimal; class 2, adequate; class 3, inadequate) according to the predischarge echocardiograms analyzed in a core laboratory and unplanned reinterventions that occurred before discharge from the Norwood hospitalization.
Cardiol Young
December 2013
5 Johns Hopkins All Children's Heart Institute, Johns Hopkins University, Saint Petersburg, Tampa, and Orlando, Florida, United States of America.
Tetralogy of Fallot is the most common form of cyanotic congenital cardiac disease. Patients with previously repaired tetralogy of Fallot are the most common patients seen in the Program for Adults with Congenital Heart Disease at The Johns Hopkins All Children's Heart Institute. Guidelines for the management of these patients are available from multiple sources including The American College of Cardiology (ACC) and The American Heart Association (AHA), The Canadian Cardiovascular Society, and The European Society of Cardiology (ESC).
View Article and Find Full Text PDFCardiol Young
December 2013
2 Johns Hopkins All Children's Heart Institute, St. Petersburg, Florida, United States of America.
Tetralogy of Fallot is the most common cyanotic heart defect seen in children beyond infancy. There is considerable variation in surgical management today ranging from differences in timing of complete repair versus initial use of a shunt for palliation, and methods for right ventricular outflow tract reconstruction. This article will examine some of the current surgical management techniques for patients with Tetralogy of Fallot.
View Article and Find Full Text PDF